Intensity Therapeutics公司近日提出一项方案修订,计划减少药物使用量并改为单次注射Int230-6。这一调整旨在优化治疗方案,可能提升患者的治疗体验并降低潜在风险。
Intensity Therapeutics公司近日提出一项方案修订,计划减少药物使用量并改为单次注射Int230-6。这一调整旨在优化治疗方案,可能提升患者的治疗体验并降低潜在风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.